Latest United States Army Medical Research Institute of Infectious Diseases Stories

Inovio to Advance Painless Device to Simultaneously Deliver Multiple Vaccines Using Electroporation Technology BLUE BELL, Pa., April 10, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has been selected to receive a $3.5 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance the development of its next generation DNA vaccine delivery device capable of simultaneously administering multiple synthetic vaccines via skin surface...

Treatment with JPM-TMTFunded AVI-7288 Shows Significant Survival Rates Even When Administered up to Four Days Post Infection FORT BELVOIR, Va., Aug. 2, 2012 /PRNewswire-USNewswire/ -- A new study testing a drug candidate to treat Marburg virus demonstrated significant survival rates up to four days after exposure to the disease. Referred to as AVI-7288, the drug is a post-exposure prophylactic targeting the Marburg virus which may cause hemorrhagic fever, a severe,...

Army scientists and industry collaborators have successfully protected laboratory animals from lethal hantavirus disease using a novel approach that combines DNA vaccines and duck eggs. The work appears in a recent edition of the online scientific journal PLoS ONE, published by the Public Library of Science. According to first author Jay W. Hooper of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), this is the first time that the DNA vaccine/duck egg system has...

ORLANDO, Fla., Jan. 31, 2012 /PRNewswire/ -- The U.S. Army Engineering and Support Center, Huntsville, awarded Lockheed Martin (NYSE: LMT) a $66 million contract to stand up the U.S. Army Medical Research Institute of Infectious Diseases Replacement Laboratory at Fort Detrick, Md. Through the six-year contract, Lockheed Martin's Global Training and Logistics business will help transition essential personnel and equipment to the new facility, which includes nearly one-million...

Vaccination with the anthrax capsule—a naturally occurring component of the bacterium that causes the disease—protected monkeys from lethal anthrax infection, according to U.S. Army scientists. The study, which appears in the Jan. 20th print edition of the journal VACCINE, represents the first successful use of a non-toxin vaccine to protect monkeys from the disease. Bacillus anthracis, the bacterium that causes anthrax, is recognized as one of the most serious bioterrorism threats. It...

CHARLOTTESVILLE, Va., Jan. 5, 2012 /PRNewswire/ -- ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, and the US Army Medical Research Institute of Infectious Diseases (USAMRIID), today announced the signing of a Cooperative Research and Development Agreement (CRADA) for the development of simplified sample processing solutions for biothreat agents. The two organizations will collaborate on the development, testing and...

MUNICH, Nov. 2, 2011 /PRNewswire/ -- Abbott's PLEX-ID system provides reliable and rapid results for key microbial biothreat agents and should be considered as a first line analytical tool for biodefense, biosecurity and microbial forensics programs, according to research presented at the 13th Medical Biodefense Conference in Munich. The meeting is a global congress for civilian and military researchers covering the latest developments in the diagnosis, therapy and prevention of diseases...

Research published by two teams of Army scientists and collaborators has identified a cellular protein that plays a critical role in Ebola virus infection. The findings, published online today in separate studies in the journal Nature, suggest a possible strategy for combating one of the world's most deadly viruses. Ebola causes hemorrhagic fever with case fatality rates as high as 90 percent in humans. The virus is of concern both as a global public health threat and as a potential agent...

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Biomatrica, Inc., the leader in room temperature sample storage and stabilization, and the US Army Medical Research Institute of Infectious Diseases (USAMRIID), today announced the signing of a Cooperative Research and Development Agreement (CRADA) to develop room temperature solutions for managing clinical and biological samples. The two organizations will collaborate on the development, testing, validation and eventual commercialization of new...

CLEVELAND, June 22, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing expertise in basic and applied research, clinical trials, and regulatory support, announced today it has been awarded a new, 5-year, $97MM research support contract titled Support for Military Medical Research for the Soldier (SMMRS) to be performed at the Walter Reed Army Institute of Research (WRAIR). The United States Army Medical Research...